Sources | Names Used |
---|---|
CTRPv2 | sirolimus:bortezomib (250:1 mol/mol) |
PharmacoGx | sirolimus:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IFNLR1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | HDHD2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | PPM1K | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | IRF4 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | FAM89B | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | LILRB1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | TEAD2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | MS4A1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | SPDYE3 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | MYBPC2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |